UPDATE: B.Riley Starts F-Star Therapeutics Inc. (FSTX) at Buy, PT $28, 'Building Momentum with a Next-Generation Immunotherapy Platform'
Tweet Send to a Friend
(Updated - June 9, 2021 7:17 AM EDT)
B.Riley analyst Justin Walsh initiates coverage on F-Star Therapeutics Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Justin Walsh initiates coverage on F-Star Therapeutics Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
